Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


You asked for faster speed, less cross-talk, easy operation and low cost … Shimadzu Listened!

Product Image
Product Description

To increase lab efficiency, researchers are constantly challenged to detect more target analytes with greater sensitivity in hundreds of samples per day. To meet this challenge, Shimadzu has developed the LCMS-8030, which combines the power of triple quadrupole mass spectrometry with unmatched speed to provide the ideal complement to its UHPLC systems.

Speed Beyond Comparison
The LCMS-8030 features ultrafast multiple reaction monitoring (MRM) transitions (dwell times of 1msec and pause times of 1msec), enabling data acquisition with up to 500 different channels per second. The improvements to the electronics provide ultrafast mass spectrum measurement speeds of 15,000 u/sec without sacrificing sensitivity or resolution, allowing full spectrum scans within a series of MRM measurements, and ultra-fast polarity switching (15msec) for the most information without signal deterioration.

Patented UFsweeper® technology accelerates ions out of the collision cell by forming a pseudo-potential surface. The result is high-efficiency collision-induced dissociation (CID) and ultra-fast ion transport, reducing the sensitivity losses and cross talk observed on other systems. In addition, higher radio frequency (RF) power capability minimizes pauses between each transition.

When coupled with Shimadzu’s Nexera UHPLC, the LCMS-8030 can provide reliable and accurate detection of peaks only one-second wide, maximizing UHPLC performance. With a polarity switching time of just 15 msec, ultra-fast triple quadrupole measurement time is now a reality.

Integrated Approach to Ultrafast Mass Spectrometry
The combination of the LCMS-8030 with Nexera also brings together the latest hardware on the same platform. The unified platform provides unmatched qualitative and quantitative analysis, increased productivity, and accelerated workflows for high-throughput analysis. Automated optimization of analytical conditions for each quantitative target compound, which is the key to high-sensitivity analysis, allows unattended, overnight operation. In addition, all software operations are handled seamlessly, reducing PC conflicts and the need for user intervention.

Easy Maintenance
With the LCMS-8030, maintenance has never been easier or more accessible. Its robust design allows maximum uptime, resulting in a system that can handle most complex matrices. Maintenance of the desolvation line without breaking vacuum minimizes instrument downtime.

Product You asked for faster speed, less cross-talk, easy operation and low cost … Shimadzu Listened!
Company Shimadzu
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Shimadzu
Shimadzu Scientific Instruments 7102 Riverwood Drive, Columbia, MD 21046 USA

Tel: +1 410-381-1227
Fax: +1 410-381-1222
Email: kgmclaughlin@shimadzu.com



Scientific News
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Nanoparticles Deliver Tumor Suppressors to Damaged Livers
UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Nanoparticles Proven Effective Against Antibiotic-Resistant “Superbugs”
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.

SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!